Item

Vanadium Aspartate 0.1% R13383 K (WS-81912)

Vanadium Aspartate, Sodium Sulfate, Aspartic Acid
Mineral / Salt
Attributes
  • Gluten-free
  • Ingredient declaration
Locations
Location name Address
WRIGHT PHARMA, INC. 700 Kiernan Ave. Ste. A Modesto, CA 95356
Documents
Type Location File name Effective Expiration
Allergens WRIGHT PHARMA, INC. Allergens.pdf 10/10/2024 10/10/2026
Country of Origin WRIGHT PHARMA, INC. Country of Origin.pdf 11/10/2022 11/9/2025
National Bioengineered Food Disclosure Standard (Simplified) WRIGHT PHARMA, INC. National Bioengineered Food Disclosure Standard (Simplified).pdf 11/10/2022 11/9/2025
Nutrition WRIGHT PHARMA, INC. Nutrition.pdf 7/19/2023 7/18/2026
BSE - TSE WRIGHT PHARMA, INC. WS-81912 BSE Statement.pdf 11/10/2022 11/9/2025
Gluten WRIGHT PHARMA, INC. WS-81912 Gluten Statement.pdf 10/3/2024 10/3/2026
GRAS/NDI/ODI Statement WRIGHT PHARMA, INC. WS-81912 GRAS Statement.pdf 7/15/2024 7/15/2027
Halal WRIGHT PHARMA, INC. WS-81912 Halal Compliance.pdf 11/10/2022 11/30/2023
Ingredient Statement WRIGHT PHARMA, INC. WS-81912 Ingredients Composition Range.pdf 11/10/2022 11/10/2023
Kosher WRIGHT PHARMA, INC. WS-81912 Kosher.pdf 11/10/2022 11/30/2023
GMO WRIGHT PHARMA, INC. WS-81912 Non-GMO Statement.pdf 11/10/2022 11/9/2024
EtO Statement WRIGHT PHARMA, INC. WS-81912 Organic Declaration.pdf 11/10/2022 11/30/2023
Irradiation Status Statement WRIGHT PHARMA, INC. WS-81912 Organic Declaration.pdf 10/11/2024 10/11/2026
Sewage Statement WRIGHT PHARMA, INC. WS-81912 Organic Declaration.pdf 10/11/2024 10/11/2026
California Prop. 65 WRIGHT PHARMA, INC. WS-81912 Prop 65 Statement.pdf 10/11/2024 10/11/2026
Pesticide WRIGHT PHARMA, INC. WS-81912 Residual Pesticide Statement.pdf 11/10/2022 11/9/2024
Residual Statement WRIGHT PHARMA, INC. WS-81912 Residual Pesticide Statement.pdf 11/14/2022 11/14/2023
Safety Data Sheet (SDS) WRIGHT PHARMA, INC. WS-81912 Vanadium Aspartate 0.1% SDS.pdf 10/10/2024 10/10/2027
Vegan/Vegetarian Statement WRIGHT PHARMA, INC. WS-81912 Vegan Statement.pdf 11/14/2023 11/13/2025
WADA/NSF/NFL Statement WRIGHT PHARMA, INC. WS-81912 WADA Statement.pdf 11/10/2022 11/30/2023